Preview

Real-World Data & Evidence

Advanced search

Review of the monograph by Kolbin A. S., Zyryanov S. K., Belousov D. Yu. "Pharmacovigilance" 2025

https://doi.org/10.37489/2782-3784-myrwd-063

EDN: NSKJZY

Abstract

The 2nd revised and supplemented edition of “Pharmacovigilance” has been published. This book discusses the drug safety and pharmacovigilance systems from the viewpoint of clinical pharmacology. The history of drug safety studies is given in details. The main definitions and classifications of adverse events are presented below. A separate chapter will examine the pharmacovigilance system in the EAEU member states. The textbook is intended for students, residents, postgraduates, clinical pharmacologists, physicians of other specialties, holders of registration certificates, and researchers.

About the Author

V. I. Petrov
Volgograd State Medical University
Russian Federation

Vladimir I. Petrov — DM, Professor, Academician of the Russian Academy of Sciences, President; head Department of Clinical Pharmacology and Intensive Care; chief freelance specialist — clinical pharmacologist of the Russian Ministry of Health; President of the Association of Clinical Pharmacologists

Volgograd



Review

For citations:


Petrov V.I. Review of the monograph by Kolbin A. S., Zyryanov S. K., Belousov D. Yu. "Pharmacovigilance" 2025. Real-World Data & Evidence. 2024;4(4):53-55. (In Russ.) https://doi.org/10.37489/2782-3784-myrwd-063. EDN: NSKJZY

Views: 261


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2782-3784 (Online)